Results 331 to 340 of about 126,141 (353)
Some of the next articles are maybe not open access.
Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer
Ca-A Cancer Journal for Clinicians, 2005Ruth M O'regan
exaly
Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
Nature, 2012Outi Kilpivaara +2 more
exaly
JAK inhibitors and systemic sclerosis: A systematic review of the literature
Autoimmunity Reviews, 2022exaly
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors
Ca-A Cancer Journal for CliniciansChadi Hage Chehade +2 more
exaly
Beyond suppression: the paradox of JAK inhibitors as amplifiers of cancer immunotherapy
Nature Reviews ImmunologyJohn R Teijaro
exaly
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
Nature Reviews Drug DiscoveryTeemu Haikarainen +2 more
exaly